Table 11 TOP 20 miRNA-disease resistance associations predicted by MHXGMDA.
Lung neoplasms | Carcinoma, Hepatocellular | Glioblastoma | ||||||
|---|---|---|---|---|---|---|---|---|
Ranking | miRNA | Evidence | Ranking | miRNA | Evidence | Ranking | miRNA | Evidence |
1 | hsa-mir-31 | H4 | 1 | hsa-mir-21 | H4 | 1 | hsa-mir-223 | H4 |
2 | hsa-mir-150 | H4 | 2 | hsa-mir-10b | H4 | 2 | hsa-mir-21 | H4 |
3 | hsa-mir-542 | H4 | 3 | hsa-mir-132 | H4 | 3 | hsa-mir-34a | H4 |
4 | hsa-mir-146a | H4 | 4 | hsa-mir-222 | H4 | 4 | hsa-mir-155 | H4 |
5 | hsa-mir-34a | H4 | 5 | hsa-mir-146a | H4 | 5 | hsa-mir-146a | H4 |
6 | hsa-mir-155 | H4 | 6 | hsa-mir-215 | H4 | 6 | hsa-mir-150 | Unconfirmed |
7 | hsa-mir-25 | H4 | 7 | hsa-mir-30b | H4 | 7 | hsa-mir-20a | H4 |
8 | hsa-mir-200b | H4 | 8 | hsa-mir-29c | H4 | 8 | hsa-mir-19a | H4 |
9 | hsa-mir-223 | H4 | 9 | hsa-mir-211 | H4 | 9 | hsa-mir-18a | H4 |
10 | hsa-mir-29a | H4 | 10 | hsa-mir-421 | H4 | 10 | hsa-mir-140 | H4 |
11 | hsa-mir-200c | H4 | 11 | hsa-mir-296 | H4 | 11 | hsa-mir-16-1 | H4 |
12 | hsa-mir-21 | H4 | 12 | hsa-mir-455 | H4 | 12 | hsa-mir-30e | H4 |
13 | hsa-mir-200a | H4 | 13 | hsa-mir-199a | H4 | 13 | hsa-mir-193a | H4 |
14 | hsa-mir-149 | H4 | 14 | hsa-mir-23b | H4 | 14 | hsa-mir-92b | H4 |
15 | hsa-mir-590 | H4 | 15 | hsa-mir-204 | H4 | 15 | hsa-mir-29b | H4 |
16 | hsa-mir-9 | H4 | 16 | hsa-mir-101 | H4 | 16 | hsa-mir-542 | H4 |
17 | hsa-mir-424 | H4 | 17 | hsa-mir-195 | H4 | 17 | hsa-mir-149 | H4 |
18 | hsa-let-7f-1 | H4 | 18 | hsa-mir-34a | H4 | 18 | hsa-mir-29a | H4 |
19 | hsa-mir-141 | H4 | 19 | hsa-mir-9 | H4 | 19 | hsa-mir-373 | H4 |
20 | hsa-mir-483 | H4 | 20 | hsa-mir-218-1 | H4 | 20 | hsa-mir-129 | H4 |
